articleThe LancetJan 20, 2016GREEN OA

Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial

University of California, San Diego · Stony Brook University · +10 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

511
total citations
FWCI
54.81
Percentile
100%
References
24
Citations per year

Authors

13

Topics & keywords

Keywords
  • Ejection fraction
  • Medicine
  • Heart failure
  • Placebo
  • Clinical endpoint
  • Population
  • Internal medicine
  • Ambulatory
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding